Verified email-pattern data for Sur Access is currently limited. You can still use the company insights and contact sections below.
Sur Access is a specialist consulting in market access for rare diseases, advising clients and partners on how to avoid pitfalls in rare disease drug development, strategic market positioning, reimbursement and pricing potential for your rare disease therapy.
We analyze your assets across multiple dimensions and enable you and your teams to make informed choices about the right indication, for the right patients, at the right time, on the right market and at the right price. Our mission is empowering businesses to navigate market access for rare diseases with confidence.
Sur Access also specializes in the Croatian market.
As the European Union introduces new pharmaceutical legislation aimed at expanding patient reach across the region, Sur is uniquely positioned to leverage Croatia's strategic location as a gateway to Southeast Europe. At Sur, we understand the complexities of entering new markets. That's why we offer comprehensive local expert guidance to help biotech companies navigate the Croatian market landscape. From establishing a local presence to facilitating smooth market entry, we act as your representative office in Croatia, ensuring a seamless transition. Our established relationships with key stakeholders, including healthcare providers, pharmacies, and regulatory authorities, allow us to provide invaluable insights and strategic advice on market positioning, reimbursement, and pricing potential.
Let Sur be your partner in harnessing the potential of the Croatian market for regional expansion and beyond. Connect with us to explore how we can support your company's growth and success in this dynamic region.
Company Details
- Employees
- 2
- Address
- Genève, Ch
- Industry
- Business Consulting And Services
- Website
- https://www.sur-access.com/
- Keywords
- market access, reimbursement, pricing, biotech strategy, steer investment portfolio, croatian market, croatian access, EU Pharma Legislation, rare disease, orphan disease.
- HQ
- Genève
Sur Access Questions
Sur Access's website is https://www.sur-access.com/
Sur Access's LinkedIn profile is https://ch.linkedin.com/company/sur-access
Sur Access has
2 employees.
View email and phone details for 2
employees at Sur Access.
Sur Access's industry is
Business Consulting and Services
Sur Access's top competitors are
Atopia Therapeutics,
Halo Therapeutics,
Geneva Biotech,
Antion Biosciences Sa,
Edwards Lifesciences,
Om Pharma,
Campus Biotech,
Latticepoint,
Moderna,
Mara Rating | Market Access Risk Assessment.
Sur Access's categories are Business Consulting and Services
Explore related pages
Related company profiles:
Top Sur Access Employees
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.